Abstract
Hur et al. report that fluid management guided by bioimpedance spectroscopy devices might improve cardiovascular parameters in patients on haemodialysis. However, caution is advisable when using these devices for extracellular volume assessment as overzealous reduction of target weights based on extracellular to intracellular volume ratios could cause premature loss of residual renal function.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
